miércoles, 18 de septiembre de 2019

Pharmacy head: FDA 'downplayed the problem' of Zantac-carcinogen link

Pharmacy head: FDA 'downplayed the problem' of Zantac-carcinogen link

Daily Recap

STAT Plus: Pharmacy head who researched Zantac link to carcinogen says FDA has ‘downplayed the problem’

By ED SILVERMAN


ADOBE
"We think it’s very important to understand this is an inherent problem with the drug," says David Light, CEO and co-founder of Valisure.

No hay comentarios: